SCHEMBL14404161

SCHEMBL14404161

C=C(C)Sc1c(CC(=O)OCC)[nH]c2ccc(O)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 13/20 0.48
GAA P10253 3/20 0.48
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
MAPK10 P53779 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1193860 0.84 GAA (0.48) ALOX5GAAKDM4ELMNAMEN1
SCHEMBL6222629 0.74 GAA (0.63) ALOX5GAAKDM4ELMNAMEN1
SCHEMBL3387548 0.72 ALDH1A1 (0.52) GAAKDM4ELMNAMEN1ALDH1A1
SCHEMBL25904050 0.72 GAA (0.53) ALOX5GAAKDM4ELMNAMEN1
SCHEMBL1193617 0.70 ALDH1A1 (0.50) GAAKDM4ELMNAMEN1ALDH1A1
SCHEMBL5574245 0.70 GAA (0.44) ALOX5GAAKDM4ELMNAMEN1
SCHEMBL3388720 0.70 TUBB4A (0.38) ALOX5GAAKDM4ELMNAMEN1
SCHEMBL28819187 0.70 KDM4E (0.52) GAAKDM4ELMNAMEN1ALDH1A1
SCHEMBL28819201 0.69 KDM4E (0.58) GAAKDM4ELMNAMEN1ALDH1A1
SCHEMBL7826833 0.69 GAA (0.75) ALOX5GAAKDM4ELMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070244128-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244128-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS ALOX5, ALOX15B, ALOX15 ALOX5 1/4885GAA 2900/4885KDM4E 2621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.